Phase 2a Study Initiated Evaluating RV521 for RSV

News   Sep 05, 2017 | Original story from ReViral Ltd

 
Phase 2a Study Initiated Evaluating RV521 for Respiratory Syncytial Virus Infection
 
 
 

RELATED ARTICLES

New Method to Separate Mirrored Molecules Could Lead to Safer Drugs

News

The Dionne lab is developing an optical filter to sort chiral molecules, which could lead to purer and safer drugs and agrichemicals.

READ MORE

Cancer Cells’ Energy Source Blocked by Natural Compound

News

Researchers have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.

READ MORE

How do Poison Frogs Protect Themselves Against Their Own Neurotoxin?

News

Scientists are a step closer to resolving a related head-scratcher, how do these frogs keep from poisoning themselves?

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE